Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

C.D.C. Panel Endorses Covid Vaccine Booster Shots for All Adults

Faced with rising infections and an anticipated surge in holiday travel, scientific advisers to the Centers for Disease Control and Prevention on Friday endorsed booster…

View More C.D.C. Panel Endorses Covid Vaccine Booster Shots for All Adults

F.D.A. Authorizes Coronavirus Booster Shots for All Adults

WASHINGTON — The Food and Drug Administration on Friday authorized booster shots of both the Pfizer-BioNTech and Moderna vaccines for everyone 18 and older, opening…

View More F.D.A. Authorizes Coronavirus Booster Shots for All Adults

Biden Administration Plans to Expand Covid Vaccine Production

“The idea of making a business plan with two companies rather than a public health plan is disturbing to us,” said Dr. Joia Mukherjee, chief…

View More Biden Administration Plans to Expand Covid Vaccine Production

F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Week

WASHINGTON — The Food and Drug Administration is aiming to authorize booster doses of Pfizer-BioNTech’s coronavirus vaccine for all adults as early as Thursday, a…

View More F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Week

U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People

WASHINGTON — The Biden administration plans to pay more than $5 billion for a stockpile of Pfizer’s new Covid-19 pill, enough for about 10 million…

View More U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People

Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries

DURBAN, South Africa — Pfizer announced a deal on Tuesday to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer…

View More Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries

Pfizer Asks F.D.A. to Expand Booster Eligibility to All Adults

WASHINGTON — Pfizer and BioNTech asked federal regulators Tuesday to authorize their coronavirus booster shot for those 18 and older, a move that would likely…

View More Pfizer Asks F.D.A. to Expand Booster Eligibility to All Adults
Top